iShares Core MSCI Europe ETFの空売り状況は、投資家がiShares Core MSCI Europe ETFの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

iShares Core MSCI Europe ETF (ARCA:IEUR), 空売り情報

iShares Core MSCI Europe ETF

Financial Services

Industrials

Healthcare

Technology

Consumer Defensive

Consumer Cyclical

Basic Materials

Energy

Communication Services

Utilities

Real Estate

Other

The fund generally will invest at least 90% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index which consists of securities from the following 15 developed market countries or regions: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom.

Novo Nordisk As

Asml Holding Nv Common Stock Eur 0.09

Nestle Capital Corp.

Astrazeneca Plc

LVMH Moet Hennessy Louis Vuitton SE

Siemens Ag, Registered Shares

Gold,Bar,On,Candlestick,Chart,Background.,Conceptual,Image,Of,Gold

Asia

News

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

3月17日（月）、景気指標が発表された結果、株式市場は上昇で取引を終えた。数週にわたる損失の後、投資家は打撃を受けた株を買い増しし始めた。米国ではニューヨークの製造業の活動が急速に減少し、関税の上昇によるコストが原因で住宅建設業者の景気後退は明らかである。

アジアとヨーロッパ市場が上昇、金が高値更新 - 米国が眠っている間の本日のグローバル市場

Hand,Holding,Crystal,World,With,International,Currency,Sign,Include,Dollar

Emerging Markets

3月13日（木）の米国市場は大幅下落で取引を終了、米国のインフレデータが好調にもかかわらず新たな関税が明らかになったことでS&amp;P500は調整に入った。

今日のグローバル市場⁻アジアとヨーロッパ市場は上昇、金は3,000ドル

WIIM

ETON

ETON stock has given up its prior gain. Eton Pharmaceuticals shares were trading higher after the company reported better-than-expected Q1 financial results.

Jefferies analyst Stephanie Moore maintains Hertz Global Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) with a Hold and lowers the price target from $7 to $6.

Price Target

Analyst Ratings

Jefferies Maintains Hold on Hertz Global Holdings, Lowers Price Target to $6

Needham analyst Serge Belanger reiterates Verrica Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) from Hold to Hold.

Reiteration

VRCA

Needham Reiterates Hold on Verrica Pharmaceuticalsto Hold

<a href="https://www.bloomberg.com/news/articles/2025-05-14/us-is-not-negotiating-for-weaker-dollar-as-part-of-tariff-talks">https://www.bloomberg.com/news/articles/2025-05-14/us-is-not-negotiating-for-weaker-dollar-as-part-of-tariff-talks</a>
&nbsp;

Macro Economic Events

Global

Economics

'U.S. Not Seeking To Weaken Dollar As Part Of Trade Deals' - Bloomberg

Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) CEO Brian Armstrong has called on Department of Government Efficiency contractors to apply to Coinbase to &#8220;help create a more efficient financial system for the world.&#8221;
What Happened: In a <a href="https://x.com/brian_armstrong/status/1922368587626643618">post</a> on X on May 13, Armstrong wrote &#8220;If you&#8217;re looking for your next mission to serve your country, consider taking the DOGE Staff interview, help us build a more efficient financial system for the world at Coinbase.&#8221;
He reposted a video featuring a Harvard dropout who joined the DOGE team, saying he found greater impact and purpose working on financial reform than in academia. 
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45323509/coinbase-analysts-look-ahead-to-q2-after-disappointing-q1-higher-crypto-prices-increased-volumes">Coinbase Analysts Look Ahead To Q2 After Disappointing Q1: &#8216;Higher Crypto Prices… Increased Volumes&#8217;</a>
Why It Matters: Armstrong has long <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42035165/coinbase-ceo-brian-armstrong-says-doge-department-is-a-once-in-a-lifetime-opprtunity-advocates-abolishing-individual-income-tax">championed</a> DOGE as a vehicle for financial reform, previously describing it as a "once-in-a-lifetime opportunity" to expand economic freedom in the U.S. 
In November 2024, he even proposed replacing individual income tax with corporate taxation, highlighting DOGE's role in broader policy innovation.
More recently, in May 2025, Armstrong <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45309227/coinbase-ceo-brian-armstrong-believes-traditional-banks-launching-own-stablecoins-not-necessarily-the-best-path-pitches-usdc-as-option">noted</a> that stablecoins like USDC have strong network effects and urged banks to partner with existing players rather than creating their own.
In February 2025, Armstrong <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43591727/coinbase-ceo-brian-armstrong-says-bitcoin-adoption-to-reach-billions-by-2030">likened</a> Bitcoin adoption to the early days of mobile phones and the internet, predicting billions of global users by 2030.
As Coinbase gains momentum, including its inclusion in the S&amp;P 500 Index, Armstrong's DOGE initiative may signal a deeper push toward financial system disruption from within the industry's top leadership.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45368175/cathie-wood-says-index-sensitive-managers-will-be-compelled-to-consider-coinbase-as-crypto-exchange-platform-joins-sp-500-index">Cathie Wood Says &#8216;Index-Sensitive Managers Will Be Compelled to Consider&#8217; Coinbase As Crypto Exchange Platform Joins S&amp;P 500 Index</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

COIN

Coinbase CEO Brian Armstrong Invites DOGE Staff To 'Create A More Efficient Financial System'

Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) has outperformed the market over the past 20 years by 4.63% on an annualized basis producing an average annual return of 12.91%. Currently, Applied Industrial Techs has a market capitalization of $8.91 billion. 
Buying $100 In AIT: If an investor had bought $100 of AIT stock 20 years ago, it would be worth $1,157.94 today based on a price of $232.10 for AIT at the time of writing.
<h3>Applied Industrial Techs's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747241213_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

HC Wainwright &amp; Co. analyst Scott Buck reiterates Mogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOGO#NASDAQ">MOGO</a>) with a Buy and maintains $4 price target.

MOGO

HC Wainwright & Co. Reiterates Buy on Mogo, Maintains $4 Price Target

HC Wainwright &amp; Co. analyst Kevin Dede downgrades WonderFi Techs (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WNDR#TSX">WNDR</a>) from Buy to Neutral.

Downgrades

TSX:WNDR

HC Wainwright & Co. Downgrades WonderFi Techs to Neutral

Sanofi share are trading lower after the company announced plans to invest at least $20 billion in the US through 2030.

PONY

Pony AI shares are trading lower. CNBC reported that one of the company's robotaxis caught fire.

Sanofi today announces its intention to invest at least $20 billion in the United States through 2030. The expected investment includes a significant increase in research and development spending and the allocation of billions of dollars to US manufacturing.
The announcement comes as Sanofi prepares for the potential launch of numerous new first- or best-in-class medicines across many indications in the coming years, aiming to improve the health of countless Americans. Work being done within the United States by Sanofi and by the hundreds of companies it supports is anticipated to contribute to job creation and innovation in numerous communities that are home to Sanofi and its partners, while also helping to enhance the US supply chain.

Sanofi Intends To Invest At Least $20B In US Through 2030, Growing Investments In Science And Expanding Domestic Manufacturing

ARAI

Arrive AI Receives Approval To List Its Shares On Nasdaq Under Symbol ARAI; To Begin Trading On May 15, 2025

Needham analyst Ryan Koontz reiterates Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) with a Buy and maintains $8 price target.

Needham Reiterates Buy on Planet Labs, Maintains $8 Price Target

V2X Collaborates With Bell Textron To Begin Strategic Planning For U.S. Army's Flight School Next Program

Fidelity National Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNF#NYSE">FNF</a>) has outperformed the market over the past 5 years by 1.87% on an annualized basis producing an average annual return of 16.9%. Currently, Fidelity National Finl has a market capitalization of $15.60 billion. 
Buying $100 In FNF: If an investor had bought $100 of FNF stock 5 years ago, it would be worth $215.81 today based on a price of $56.79 for FNF at the time of writing.
<h3>Fidelity National Finl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747240311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Fidelity National Finl 5 Years Ago Would Be Worth Today

VRTX

Live On CNBC, Steve Weiss Announces Sold Vertex Pharmaceuticals

Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintains Nayax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>) with a Market Perform and raises the price target from $38 to $40.

NYAX

Keefe, Bruyette & Woods Maintains Market Perform on Nayax, Raises Price Target to $40

Live On CNBC, Steve Weiss Announces Bought More UnitedHealth Group

<a href="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-belzutifan-pheochromocytoma-or-paraganglioma#:~:text=On%20May%2014%2C%202025%2C%20the,an%20oral%20therapy%20for%20PPGL" title="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-belzutifan-pheochromocytoma-or-paraganglioma#:~:text=On%20May%2014%2C%202025%2C%20the,an%20oral%20therapy%20for%20PPGL">https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-belzutifan-pheochromocytoma-or-paraganglioma#:~:text=On%20May%2014%2C%202025%2C%20the,an%20oral%20therapy%20for%20PPGL</a>.

Biotech

General

Reported Earlier: 'FDA Approves Belzutifan For Pheochromocytoma Or Paraganglioma' - FDA

BMO Capital analyst Simeon Siegel maintains Under Armour (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) with a Outperform and lowers the price target from $12 to $9.

Comments

iShares Core MSCI Europe ETF

空売り

iShares Core MSCI Europe ETF (ARCA:IEUR), 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル